LSA
IRWD icon

Leonteq Securities AG’s Ironwood Pharmaceuticals IRWD Stock Holding History

Leonteq Securities AG’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,600
Closed -$70.2K – 1247
2023
Q2 		$70.2K Buy
+6,600
New +$70.9K ﹤0.01% 757

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Leonteq Securities AG's IRWD Position: Q3 2023 in Review

Leonteq Securities AG sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 6,600 shares — an estimated $70.2K sold.

Leonteq Securities AG first reported a position in IRWD in Q2 2023 and held it in 1 quarter. The position peaked at $70.2K in Q2 2023. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

  • Leonteq Securities AG reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 6,600 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $70.2K.
  • Leonteq Securities AG first reported a position in Ironwood Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Leonteq Securities AG's Ironwood Pharmaceuticals position peaked at $70.2K in Q2 2023.
  • 248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.